Ventricular tachyarrhythmia (VT) such as Torsade de Pointes is one of the most serious adverse drug reactions which often leads to death. In vitro assessment of interaction of lead compounds with HERG potassium channel as a main known reason of VT induction is obligatory test during the drug development. However, experimental and clinical data reveal that inhibition of ion channels is not the only possible mechanism of VT induction. Therefore, identification of other protein drug targets contributing to the induction of VT is necessary. PASS prediction results include Pa -probability that drug interacts with the target, Pi -probability that drug doesn't interact with the target. In order to reveal statistically significant associations between VT and predicted human targets we calculated Mann-Whitney statistics for each target based on Pa-Pi value for each of three datasets separately and selected targets which have p<0.05 for at least two datasets. Can we identify additional VT-related protein targets?
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PASS prediction results include Pa -probability that drug interacts with the target, Pi -probability that drug doesn't interact with the target. In order to reveal statistically significant associations between VT and predicted human targets we calculated Mann-Whitney statistics for each target based on Pa-Pi value for each of three datasets separately and selected targets which have p<0.05 for at least two datasets. Can we identify additional VT-related protein targets?
Prediction for three datasets
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Discrete modeling of cardiomyocyte regulatory network behavior Cardiomyocyte regulatory network (CRN). CRN was created based on general and heart-specific signaling and regulatory pathways with a specific emphasis on identified VT-related pathways and processes. Pathways and corresponding reactions between proteins were retrieved from KEGG, freely available pathway map of MetaCore TM and PROTEOME TM BIOBASE GmbH. CRN contains 1026 nodes (proteins and genes) and 2952 directed edges (divided on two types: activation and inhibition).
Algorithm of discrete dichotomic modeling. This algorithm allows performing simulation of large regulatory networks behavior. Each node of dichotomic network model can be in two states: 1 (active) and 0 (inactive). The state of each node is calculated at each step of modeling as S(t+1) = θ(a i + ∑ k S k (t)b k ), where S(t+1) is a current state of node, S k (t) is a states of upstream nodes at previous step of modeling, b k is weights of input edges: 1 (activation) or -1 (inactivation).
Parameter a i may be used for more accurate adjustment of the model according to the known data on regulatory processes. Initial state in CRN dichotomic model corresponds to 60 housekeeping genes presenting in network and was considered as S(0) = 1.
Key events. Dichotomic modeling allows identifying nodes of network whose inhibition can lead to a selected key event.
The selected key events correspond to the activation/inactivation of a fragment of network or distinct nodes. We found in literature 26 proteins which inhibition can lead to VT in mouse models. We selected inactivation of each of 26 proteins in CRN dichotomic model as key events and searched for other CRN proteins, whose inhibition can lead to these key events, by simulation of CRN behavior. 
Training results
The most common type of the revealed targets is kinases (90 targets). They regulate activity of cell ion homeostasis and therefore contribute to VT induction. Low confidence category. Contains 165 targets: (1) targets which can be revealed by statistical analysis of predicted drug target interactions, but which don't have support in literature or CRN simulation results; (2) targets which were revealed by simulation of CRN behavior, but were not revealed by statistical analysis of predicted drug target interactions.
Target name Gene Brief description
Advanced glycosylation end product-specific receptor (AGER) AGER 
